ATAI Life Sciences NV (ATAI)
1.67
-0.01
(-0.60%)
USD |
NASDAQ |
May 22, 16:00
1.67
0.00 (0.00%)
After-Hours: 20:00
ATAI Life Sciences Total Assets (Quarterly): 269.12M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 269.12M |
| December 31, 2023 | 293.48M |
| September 30, 2023 | 308.22M |
| June 30, 2023 | 253.60M |
| March 31, 2023 | 280.72M |
| December 31, 2022 | 305.44M |
| September 30, 2022 | 342.60M |
| Date | Value |
|---|---|
| June 30, 2022 | 348.94M |
| March 31, 2022 | 383.73M |
| December 31, 2021 | 414.17M |
| September 30, 2021 | 484.11M |
| June 30, 2021 | 505.96M |
| March 31, 2021 | 145.26M |
| December 31, 2020 | 111.55M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
111.55M
Minimum
Dec 2020
505.96M
Maximum
Jun 2021
317.63M
Average
306.83M
Median
Total Assets (Quarterly) Benchmarks
| Affimed NV | 107.40M |
| InflaRx NV | 115.65M |
| MorphoSys AG | 2.240B |
| BioNTech SE | 24.04B |
| Immatics NV | 705.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 45.86M |
| Shareholders Equity (Quarterly) | 222.54M |